Literature DB >> 8396835

Motor neuron disease with pallido-luysio-nigral atrophy.

M Bergmann1, K Kuchelmeister, A Migheli, D Schiffer, F Gullotta.   

Abstract

A case of motor neuron disease (MND) with pallido-luysio-nigral atrophy (PLNA) is reported. The 45-year-old male patient presented with lower motor neuron symptoms and signs of basal ganglia disturbance. He died after a progressive course of 7 months. Neuropathological examination revealed motor neuron loss at all spinal cord levels with sparing of Onuf's nucleus. Nerve cell loss and gliosis were also present in substantia nigra, globus pallidus, and subthalamic nucleus. The presence of ubiquitin-positive inclusions, a hallmark of most variants of MND, confirms this case as an example of MND. At immunoelectron microscopy the granules were distributed on filamentous material. The combination of clinically apparent PLNA with MND has only been described twice previously. The relationship of this syndrome to other forms of MND and its nosological placement are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396835     DOI: 10.1007/bf00454908

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Amyotrophic lateral sclerosis.

Authors:  T LAWYER; M G NETSKY
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-02

2.  Sporadic amyotrophic lateral sclerosis with extensive neurological involvement.

Authors:  S Sasaki; Y Tsutsumi; K Yamane; H Sakuma; S Maruyama
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Ubiquitin in motor neuron disease: study at the light and electron microscope.

Authors:  D Schiffer; L Autilio-Gambetti; A Chiò; P Gambetti; M T Giordana; F Gullotta; A Migheli; M C Vigliani
Journal:  J Neuropathol Exp Neurol       Date:  1991-07       Impact factor: 3.685

4.  [Striato-nigral degeneration (SND): a multisystem atrophy?].

Authors:  M Bergmann; K Schmidtke; A Danek; F Gullotta; P Mehraein
Journal:  Schweiz Arch Neurol Psychiatr (1985)       Date:  1990

5.  Amyotrophic lateral sclerosis/parkinsonism/dementia: clinico-pathological correlations relevant to Guamanian ALS/PD.

Authors:  A J Hudson
Journal:  Can J Neurol Sci       Date:  1991-08       Impact factor: 2.104

6.  Primary non-Hodgkin lymphomas of the CNS. Classification, tissue reaction and proliferative activity.

Authors:  M Bergmann; K Kuchelmeister; G Edel; A Heinecke
Journal:  Zentralbl Pathol       Date:  1993-03

7.  Familial motor neuron disease with Lewy body-like inclusions in the substantia nigra, the subthalamic nucleus, and the globus pallidus.

Authors:  C Tranchant; M H Dugay; M Mohr; P Wasser; J M Warter
Journal:  J Neurol Sci       Date:  1992-03       Impact factor: 3.181

8.  Luyso-pallido-nigral atrophy and amyotrophic lateral sclerosis.

Authors:  F Gray; J F Eizenbaum; R Gherardi; J D Degos; J Poirier
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions.

Authors:  M B Delisle; P Gorce; E Hirsch; J J Hauw; A Rascol; H Bouissou
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  Pallido-luyso-nigral atrophy and amyotrophic lateral sclerosis.

Authors:  F Gray; C De Baecque; M Serdaru; R Escourolle
Journal:  Acta Neuropathol Suppl       Date:  1981
View more
  3 in total

Review 1.  Parkinsonism in motor neuron disease: case report and literature review.

Authors:  T L Williams; P J Shaw; J Lowe; D Bates; P G Ince
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

2.  Infantile multiple system atrophy with cytoplasmic and intranuclear glioneuronal inclusions.

Authors:  M Bergmann; K Kuchelmeister; B Kryne-Kubat; F Burwinkel; K Harms; F Gullotta
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 3.  Pallidal degenerations and related disorders: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-08-07       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.